These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33424830)

  • 1. Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.
    Liu Y; Xie P; Jiang D; Liu J; Zhang J; Bian T; Shi J
    Front Immunol; 2020; 11():568440. PubMed ID: 33424830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.
    Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X
    Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma.
    Zhang L; Wang S; Wang L
    BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
    Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
    Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma.
    He M; Zhi Y; Li C; Zhao C; Yang G; Lv J; You H; Huang H; Cao X
    Aging (Albany NY); 2024 Jul; 16(14):11318-11338. PubMed ID: 39028290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 17. High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma.
    Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q
    Curr Mol Med; 2024; 24(6):801-812. PubMed ID: 37340746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
    Fang L; Yu W; Yu G; Zhong F; Ye B
    Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
    Luo C; Lei M; Zhang Y; Zhang Q; Li L; Lian J; Liu S; Wang L; Pi G; Zhang Y
    J Cell Mol Med; 2020 Jan; 24(2):1233-1244. PubMed ID: 31779055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.